Neues zur symptomatischen MS-Therapie: Teil 5 – Fatigue
Crossref DOI link: https://doi.org/10.1007/s00115-017-0442-8
Published Online: 2017-10-27
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Henze, T.
Feneberg, W.
Flachenecker, P.
Seidel, D.
Albrecht, H.
Starck, M.
Meuth, S. G.
License valid from 2017-10-27